BioSpace News Archive

ClearPoint Neuro, Inc. provided an update with respect to the COVID-19 pandemic and announced preliminary financial results for the quarter ended March 31, 2020.

Emmaus Life Sciences, Inc., a leader in sickle cell disease treatment, announced that the SFDA has accepted its request for priority review of Endari®, its prescription grade L-glutamine oral powder.

New Solutions Will Provide Critical Transparency to the Life Sciences Supply Chain, Mobilizing Companies to Rapidly React to Unforeseen Disruptions and Ensure Medicine Supply

An international research network centers around ReFRAME, the world’s leading collection of drugs known to be safe in humans

Heska Corporation (NASDAQ: HSKA; “Heska” or the “Company”), a provider of advanced veterinary diagnostic and specialty products, plans to report its first quarter 2020 financial performance in a press release on Thursday, May 7, 2020 before the market opens, and to host a earnings call to discuss the results following the release

Ikonopedia is Providing Web-Based Training and Installation to Help Customer Base Leverage Efficiency Gains to Handle Anticipated Patient Volumes Post COVID-19

Avectas, an Irish based cell engineering technology business, has completed a significant new Series C equity funding of approximately $20 million, bringing the total equity invested in the business to date to $40 million.

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its first quarter 2020 financial results and provide an update on the company’s business and outlook on Thursday, April 30, 2020 at 4:30 p.m. (ET) after the closing of the market. The call can

Vyaire is one of seven companies awarded contracts to ramp up ventilator production

Indivior PLC announced the publication of long-term safety data for SUBLOCADE® injection, for subcutaneous use.